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Abstract 
Chemerin may play a role in connecting inflammation and metabolic syndrome(MS), C-reactive 
protein(CRP) level is markedly rising during infectious and inflammatory diseases . The aimed of this 
study to evaluate both  C- reactive protein  (CRP)  and Chemerin as  subclinical markers in diabetic patients 
women. A total of 90 women, including, 24 healthy women (as control group), 66 women patients with  
diabetes mellitus type 2 (T2DM) (22diabetics with hypertension, 22 diabetics without hypertension and 22 
hypertension only),there ages ranged between49-64 years. The result showed that  significant increase 
(p≤0.05) in mean chemerin level in the diabetes group (8.766 ±0.648 ng/ml) in comparison with control 
group( 4.042±0.320 ng/ml). Also, the result, revealed that significant increase (P<0.05) in the level of 
chemerin in women suffering from hypertension and diabetes  (14.108 ± 0.577 ng/ml) in comparison to the 
women suffering from diabetic  only which reached (8.766 ± 0.648 ng/ml). The data pointed out that the 
serum CRP level significant increase in T2DM group (6.176±0.1905) compared with control group 
(2.20±0.15 ng/ml) . Also, the result revealed that significant increase (P<0.05) of the CRP level with 
hypertension women patients (4.45 ± 0.131ng/ml) compared with the control group( 2.20±0.15 ng/ml) and 
significant increase(P<0.05) in diabetic with hypertension women group patients comparison with the 
women suffering from diabetic  only. The chemerin and C-RP  in hypertensive and normotensive patients 
with T2DM may be play an important role in activation of Immune Response in these patients . 
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ةصلاخلا 
      د نيرمكلا بعمي  طبر يف ًارو  ةمزلاتملا، تاباهتللااو ةيضيلأا  ذأعفتري   ىوتسم نيتوربلعافتلا  ضارملأا يف اظوحمم اعافترا  يس
يمعافتلا يس نيتورب نم لك مييقت ىلا  ةساردلا هذه تفده. تاباهتللااو ةيدعملا (CRP)  صيخشت يف ةدعاسم ةيريرس تاملاعك  نيرمكلاو
ف يركسلا ضرم .ءاسنلا يتممش  ةساردلا00 ةارما ( نيب نهرامعأ تحوارت ،74-47 ،ةنس )47  ،)ةرطيس ةعومجم( ةحيحص ةارما44  ةارما
 يناثلا عونلا يركسلا ضرم نم نيناعي(T2DM) type2diabetics (،44  يركسلا ءاد نم نيناعي ةارما و مدلا طغض عافترا عم44 
و مدلا طغض عافترا نود  يركسلاب تاضيرم44  جئاتنلا ترهظأ .)طقف  مدلا طغض عافترا نم نيناعي دوجو ةيونعم ةدايز(p  ≤0.05)   يف
( يركسلا ةعومجم يف  نيرمكلا ىوتسم0.470 ±0.444 ( ةرطيسلا ةعومجمب ةنراقم )رتميممم/مارغونان( 4.042±0.320 ng/ml  لذكو  ك
ةيونعم ةدايز(P<0.05)   يركسلاو مدلا طغض عافترا نم نيناعي يئلالا ءاسنلا يف  نيرمكلا ىوتسم يف(14.108 ± 0.577ng/ml)  
 طقف يركسلا نم نيناعي يئلالا ءاسنلا عم ةنراقملاب(8.766 ± 0.648ng/ml)تن تنيب .جئا  نيتورب  ىوتسم لعافتلا ةدايز لوصح  يس
 ةيونعم(P<0.05)  يف م يركسلا ءاد نم نيناعي يئلالا ءاسنلا ةعومج(6.176±0.190ng/ml)  ةرطيسلا ةعومجم عم ةنراقم
(2.2±0.15 ng/ml) ةيونعم ةدايز جئاتنلا تنيب ،كلذك .(P<0.05)   ىوتسم يف  نيتورب لعافتلا عافتراب تاباصملا ءاسنلا يف  يس
  طقف مدلا طغض(4.45 ± 0.131ng/ml) طيسلا ةعومجم عم ةنراقم ةر(2.2±0.15 ng/ml) ةيونعم ةدايزو (P<0.05)  تاضيرم يف
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نيتوربو  نيرمكلا تايوتسم نوكت دق. طقف يركسلا ءاد نم نيناعي يتلالا ءاسنلا  عم ةنراقم مدلا طغض عافترا عم يركسلا لعافتلا  يف ا يس
 امبر يركسلا ءاد عم يعيبطلا مدلا طغضو مدلا طغض عافترا ىضرميف امهم ارود بعمت ت  .ىضرملا ءلاؤه ىدل ةيعانملا ةباجتسلاا طيشن 
 مدلا طغض،يناثلا عونلا يركسلا ءاد ال :ةيحاتفملا تاممك،نيرمكلا ،ءاسنلا  لعافتلا نيتورب–،يس  
 
Introduction 
The pervasiveness type 2 diabetes Mellitus (T2DM)is increasing rapidly 
increasing  worldwide (WILd et al.,  2004) Hypertension is extremely Common nearly 
70% of patients with diabetes. (Klein  et al.,  1996). 
  Therefore, hypertension and Diabetes, have a significantly impact on  public 
health  , life quality and clinical care, (Neuparth  et al., 2014). Chemerin, one of the 
adipokines, was found to enhance insulin signaling, to increase insulin-stimulated glucose 
transport, and to regulate insulin sensitivity in the adipose tissue (Wang et al. 2013); it is 
originaly well-known as a chemoattractant to Immune cells(Wittamer et al. 2003) that 
may have a role in adaptive and innate Immunity (Ernst and Sinal, 2010).  However, The 
chemerin actions, stay unclear.  pro-chemerin processing could lead to activation form 
with inflammatory properties or with anti- inflammation (Du and Leung, 2009).  
There has been an increase importance in the contribution of low grade 
Inflammation In the pathogens of T2DM (Pickup, 2004). Interleukins 1 and 6   and tumor 
necrosis factor- are cytokines, stimulation an inflammatory marker CRP producing and 
releasing via the liver, Also Inflammation may be assumed to be playing  an important 
role in the pathogenesis of T2DM. Recently,the studies had proposed that raised CRP 
level is connected with an increased risk of the  Diabetes Mellitus evolution  
(Laaksonen et al., 2004; Jager , et al. 1999) . The circulating chemerin levels and CRP in  
hypertensive  and normotensive patients with T2DM were evaluated 
 )Neuparth et al. 2014). 
 
Material and Subjects  
      90 menopausal women involved in this study, aged between (47-64) years ,24 
menopausal women healthy subjects as control group , and  66 menopause women 
patients with type 2 diabetic divided into three groups {Diabetic normotensive n=22, 
Diabetic with  Hypertensive 22,and   Hypertensive only  22} , Blood pressure was 
estimated with  mercury sphygmomanometer  . 
 
 Estimation of  the level of Fasting Blood Glucose  
Glucose in serum blood was estimated by Glucose kit supplied via Bio Marieux , 
France. 
Estimation of the level Chemerin. 
  The human Chemerin was estimated by ELISA according to the  kit was suppling 
By Ray Biotech, Inc. U. S. A. (Cat#: ELH-Chemerin-001)) 
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Determination of Serum CRP.  
The human C-RP concentrations was estimated  by ELISA kit was supplied  by  
Elabscience Biotechnology Co., Ltd.( Catalog No: E-EL-0043). 
Statistical Analysis   
The data were  analyzed  using completely randomized design (CRD) , and the value at 
least significant difference (LSD) and T-test (student).  
  The means of the groups and Standard Error were compared at a significant level 
(p<0.05). The correlation between study parameters were done.   
 
Results 
The result of current study for blood sugar level in women  suffering from DM , 
pressure and DM with pressure showed that  significant increase  (p  < 0.05) of blood 
sugar in women patients with DM and DM with pressure when compared with healthy 
women and pressure only ,also there was a significant increase (p< 0.05) in women DM 
with pressure comparison with DM only (Fig. 1). There was a significantly differe 
between the 2 group according to the level of serum chemerin , being greater in the DM 
pat ients than in the healthy women (p < 0.5), ( Fig. 2). 
The  CRP levels in DM women were more significant difference when compared 
to their non diabetic group  (P < 0 .05) level of CRP being greater in the DM patients 
with pressure than with diabetic patients only (Fig. 3). 
 
 
 
 
 
 
 
 
 
 
 
Different symbols (abcd) mean significant at (P<0.05) 
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Figure 1: Serum  sugar level in women patients in DM, pressure and DM with 
pressure and healthy group. 
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Figure. 3:The level of C - reactive protein in women patients in DM, pressure and DM 
with pressure and healthy group. 
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Fig. 2: Serum  Chemerin level in women patients in DM, pressure and DM with 
pressure and healthy group. 
a 
b 
c 
d 
Journal of Babylon University/Pure and Applied Sciences/ No.(1)/ Vol.(26): 2018 
131 
 
There was positive significant correlation   between the level of serum chemerin with 
DM, and DM plus pressure; while, there was no-significant (p>0 .05) correlation between 
level of serum chemerin with pressure as showen in table( 1). 
  Farthermore, the data demonstrated that a positive significant correlation between CRP 
level with DM , pressure and DM plus pressure (table 2). 
serum  reactive protein and  -C  between ioncorrelat significantThere was positive 
correlation between  significant-nonbut  ,pressurewith DM  and DM withchemerin 
chemerin and CRP with pressure  only ( table 3). 
Table (1): Correlation coffeicint between chemerin with DM, pressure and DM plus 
pressure in women patients.                                                  
Groups parameters 
Chemerine 
r                                      P 
DM                                     + 0.521                            0.047 
pressure                                   +0.374                                    0.2     
DM with Pressure             + 0.662                                 0.007 
 
Table  (2): Correlation coffeicint between CRP with DM, pressure and DM plus 
pressure in women patients. 
Groups parameters 
CRP 
r                                      P 
   DM                                         +  0.678                              0.008                  
        Pressure                                    + 0.431                                  0.04      
DM with Pressure                           + 0.511                               0.03                    
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Table(3): Correlation coffecient between chemerin and CRP in diabetes, pressure 
and diabetes with pressure patients. 
Groups parameters 
Chemerin+ CRP 
r                                    P 
             DM                                    +  0.596                             0.02                      
        pressure                                 + 0.374                              0.2                        
DM with Pressure                         0.62                                0.01                      
 
Discussion 
In the present study, there were a significant increase between the diabetic 
patients  and healthy group regarding to the serum chemerin level; being high level in 
T2DM patients, comparison with healthy women. These results are agreed with the 
findings reported by other studies that demonstrated that chemerin level were 
significantly increased in patient group with type2 diabetes in compared with nondiabetic 
individuals (Ali and Al Hadidi, 2013; el-Mesallamy e t a l., 2 011; Hu And Feng, 2 011).  
Whether elevated chemerin was a cause or a result of T2DM still unclear, but 
other studies found chemerin on murine C2CL2 myoblasts was effected by insulin 
resistance through nuclear f actor-κB pathway-mediated  reaction of inflammatory 
(Huang and Xie,2015); Additionally,this proposal presumably varies with the Takahashi 
et al. (2008),chemerin which has the reverse influence ,and may be increased absorption 
of insulin stimulation in adipocytes through modulating and induce insulin sensitivity. 
And then rise in the chemerin level was a compensatory mechanisms insulin resistance 
patients. Also, chemerin might play a different role in endocrine function and 
autocrine/paracrine .In mice that deficient in chemerin is glucose intolerance and glucose 
intolerant was mostly owing chemerin controls beta-cell role and action an important 
function in hemostasis of glucose in a tissue dependent way 
 (Takahashi et al. 2011).                                                                                    
Also our study is consistent with a study  of  Mesallamy et.al. (2012) who found a 
significant  increase in the level of serum chemerin in patients suffering with T2DM 
comparison with healthy people, as well as in our study results showed highly significant 
increase in the level of chemerin in patients with diabetes and blood pressure compared 
with patients suffering  diabetes without blood pressure. The result of this study was in 
agreement with the study of Yang et.al.,(2010)  who revealed that level of serum 
chemerin is increased markedly in patients suffering from T2DM 
plus blood pressure compared with patients with T2 DM and healthy group . According 
to these results, this relationship of blood pressure - chemerin, might be related to the 
great chemerin expression with in the kidney, a key location to regulation of blood 
pressure. Our results suggests that, in diabetes and hypertension patients women, high 
levels of chemerin are not related to hypertension only, but also may be associated with 
diabetes itself and obesity. It appears that an adipocytes dysfunction happens 
 (Neupart  et al., 2014)  . 
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  The results noted that C-RP is significantly greater in the diabetic women 
patients compared with a healthy group. These results are compatible with those found by 
Thejaswini et al. (2013), who described a higher hs-C-reactive protein in T2 DM patients. 
Since, hs-CRP is considered to be a sensitive indicator of inflammation, a higher hs-CRP 
level in Type 2 diabetic patients may suggest that inflammation could be involved in the 
pathogenesis of diabetes and early atherosclerotic processes (Nagwa et al. 2016 ),also, 
raised levels of C- reactive protein is related to the elevated   blood pressure 
 (Dauphinot et al., 2009, Davey smith  et al., 2005) as well as with insulin resistance  
(XU et al., 2008).  There was a relationship between serum chemerin and hs-CRP levels 
which is consistent with the findings of other studies (Weigert et al., 2010; Lehrke et al., 
2009; Bozaoglu et al. 2009).The levels of chemerin were positively associated with CRP 
and that it may also be correlated with the development of cardiac  artery disease  
(Dong et al., 2011). Other studies have  suggested that the increased  serum chemerin 
levels could be strongly associated with the markers of inflammation such as  C- reactive 
protein (Weigert  et al., 2010; Lehrke et al ., 2009). 
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